Main Article Content


This study was done to test the neuroprotective effects of Tecoma stans against brain ischemia/reperfusion caused oxidative stress in the rats. The global cerebral ischemia was generated in male albino Wistar rats by occluding the bilateral carotid arteries for 30 min followed by 1 h and 4 h reperfusion. The levels of malondialdehyde (MDA), glutathione peroxidase (GPx), glutathione reductase (GR), glutathione-s-transferase (GST), and hydrogen peroxide (H 2 O 2 ) activity, as well as brain water content, were examined at various periods after reperfusion. Ischemic alterations were preceded by a rise in MDA and hydrogen peroxide concentrations, followed by a reduction in GPx, GR, and GST activity. Ischemia-induced oxidative stress was greatly reduced after treatment with T.stans. In the groups pre-treated with methanolic extract (250 and 500 mg/kg, administered orally in single and double doses/day for 10 days), T.stans administration dramatically reversed and restored to near normal levels in a dose-dependent manner. In the ischemia reperfusion animals, T.stans reversed the cerebral water content. The neurodegenaration also confirmed by the histopathological changes in the cerebral-ischemic animals. The findings from the present investigation reveal that T.stans protects neurons from global cerebral-ischemic injury in rat by attenuating oxidative stress.


Brain edema global cerebral ischemia histopathology oxidative stress Tecoma stans

Article Details

How to Cite
Sudhanshu Bansal, Sandeep Singh Chouhan, Gurpreet Singh Multani, Shivam Choudghal, Gurinder kaur, & Dharampreet Singh. (2022). Neuroprotective activity of tecoma stans on cerebral ischemia/reperfusion induced oxidative stress in rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 11(1), 16-26.


  1. 1. Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, et al. Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 1992;23:1551-5
  2. 2. Waugh A, Grant AL. Ross and Wilson Anatomy and Physiology. 9 th ed. New York: Churchil Livingstone; 2006. p. 117-80.
  3. 3. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, Floyd RA, et al. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 1990;87:5144-7.
  4. 4. Bromont C, Marie C, Bralet J. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 1989;20:918-24.
  5. 5. Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull 1993;49:577-87.
  6. 6. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999;9:119-31.
  7. 7. Rice-Evans C. Flavanoids antioxidants. Curr Med Chem 2001;8:797-807.
  8. 8. Parrotta J A Healing plants of Pennisular india. CABI publishing 2001;701-02.
  9. 9. K.N.V Rao et al. establishment of two varieties in tecoma stans ofindian origin pharmacolognostically and pharmacologically. J.Phytology 2010;2:92-102.
  10. 10. Khare.CP Indian medicinal plants and illustrated dictionary. Springer science publishers, new delhi.2007.
  11. 11. Dr.R.Manivannan, Mr.S.Kameshwaran, Mr.M.Sarbudeen, Mr.G.Sureshkumar, Mr.N.Elavarasan, Mrs.S.Harshini. Potency of Tecoma stans flowers on atherothrombosis (In Vitro). International Journal of Allied Medical Sciences and Clinical Research Vol-8(2) 2020 150-154.
  12. 12. Kameshwaran.S, Dr.N.Sriram, Dr. Rajaneeekar Dasari, Asok Kumar DS, Abhenaya.K, Antihyperlipidemic activity of flower extract of Tecoma stans against dexamethasone-induced hyperlipidemia in rats. Int. J. of Allied Med. Sci. and Clin. Research Vol-8(3) 2020, 622-628.
  13. 13. S.Kameshwaran, R.Sundara Ganapathy, S.Arun, C.Dhanapal, Effects of Tecoma stans extract on hepatic and cardiovascular disease (CVD) markers in Streptozotocin induced diabetic albino rats. International Journal of Pharmacological screening methods, Vol 5 / Issue 2 / 2015 / 107-112.
  14. 14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
  15. 15. Fotheringham AP, Davies CA, Davies I. Oedema and glial cell involvement in the aged mouse brain after permanent focal ischemia. Neuropathol. Appl Neurobiol 2000;26:412-23. Prakash T, Rama Rao N, Viswanathaswamy AHM. Neuropharmacological studies on Tecoma stansLess stem extract. Phytomedicine 2008;15:959-70.
  16. 16. Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996;27:327-31.
  17. 17. Macdonald RL, Stoodley M. Pathophysiology of cerebral ischemia. Neurol Med Chir (Tokyo) 1998;38:1-11.
  18. 18. Sakamoto A, Ohnishi ST, Ohnishi T, Ogawa R. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res 1991;554:186-92.
  19. 19. Cui Ke, Luo X, Xu K, Ven Murthy MR. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:771-99.
  20. 20. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998;18:205-13.
  21. 21. Gutteridge JMC, Halliwell B. Antioxidant: elixirs of life or media hype? Antioxidants in Nutrition, Health and Disease. Oxford: Oxford University Press; 1994. p. 40-62.
  22. 22. Ravindranath V, Reed DJ. Glutathione depletion and formation of glutathione-protein mixed disulphide following exposure of brain mitochondria to oxidative stress. Biochem Biophys Res Commun 1990;169:1075-9.
  23. 23. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000;62:649-71.
  24. 24. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B, et al. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997;324:25-8.
  25. 25. McCord JM. Are free radicals a major culprit? In: Hearse DJ, Yellon DM, editors. Therapeutic approaches to myocardial infarct size limitation. New York: Raven Press; 1984. p. 209-18.
  26. 26. Harrigan MR, Ennis SR, Sullivan SE, Keep RF. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wein) 2003;145:49-53.